By reducing cholesterol biosynthesis at this early rate-limiting step (93), statins lead to compensatory LDLR expression and reduced serum LDL-cholesterol which should be beneficial in the context of hyperlipidemia and its effect on TB pathogenesis. This evidence concerns the gene LDLR and tuberculosis.